Company news
Nanalysis Scientific Corp (TSXV:NSCI) news
Every Nanalysis Scientific Corp press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Nanalysis Announces Second Quarter 2026 Results
August 24, 2026
Nanalysis Announces Second Quarter 2026 Conference Call
August 18, 2026
Nanalysis Provides Business Update Highlighting Quantum Technology Partnerships, $1Million in Non-Dilutive Non-Repayable Funding Award, C...
June 23, 2026
Nanalysis Announces First Quarter 2026 Results
May 20, 2026
Nanalysis Announces First Quarter 2026 Conference Call
May 13, 2026
Nanalysis Announces Board Transition and Appointment of Three New Directors
May 1, 2026
Nanalysis Announces Fourth Quarter and Full Year 2025 Results
April 8, 2026
Nanalysis Announces Fourth Quarter and Full Year 2025 Conference Call
April 2, 2026
Nanalysis Announces Grant of Options and Restricted Share Units
March 4, 2026
Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering
January 26, 2026
Nanalysis Announces Upsize to Private Placement and Closing of the First Tranche
December 23, 2025
Nanalysis Announces $2.5 Million Private Placement
December 8, 2025
Nanalysis Announces Third Quarter 2025 Results
November 24, 2025
Nanalysis Announces Third Quarter 2025 Conference Call
November 18, 2025
Nanalysis Announces Change of Management
November 14, 2025
Nanalysis announces support from Wiley for NMR Instruments in KnowItAll 2026
October 7, 2025
Nanalysis Chosen by IMRIS as Critical Component MRI Supplier
September 3, 2025
Nanalysis Announces Second Quarter 2025 Results
August 28, 2025
Nanalysis Announces Second Quarter 2025 Conference Call
August 21, 2025
Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia ...
July 9, 2025
Nanalysis Announces Closing of Fully Subscribed Note Offering
June 13, 2025
Nanalysis Announces Fully Subscribed $2 Million Note Offering
June 6, 2025
Nanalysis Announces Note Offering of $2 Million
June 6, 2025
Nanalysis Announces First Quarter 2025 Results
May 28, 2025
Nanalysis Announces First Quarter 2025 Conference Call
May 15, 2025
Nanalysis Announces Fourth Quarter and Full Year 2024 Results
April 24, 2025
Nanalysis Announces Fourth Quarter and Full Year 2024 Conference Call
April 17, 2025
Nanalysis Announces Release of Automation Software
March 18, 2025
Nanalysis Announces Next Generation 60MHz Benchtop NMR Spectrometer
March 5, 2025
Nanalysis Provides Fourth Quarter Preview (Unaudited)
February 27, 2025
Nanalysis and The United States Pharmacopeia (USP) Co-Publish Study Demonstrating Efficacy of Benchtop NMR for Quality Control
December 11, 2024
Nanalysis Announces Third Quarter 2024 Results
November 21, 2024
Nanalysis Announces Third Quarter 2024 Conference Call
November 7, 2024
Nanalysis to Present at the LD Micro Main Event XVII
October 22, 2024
Nanalysis Scientific Corp. to Present at the 2024 Cantech Letter Conference in Toronto, ON
October 3, 2024
Nanalysis Announces Second Quarter 2024 Results
August 28, 2024
Nanalysis Announces Second Quarter 2024 Conference Call
August 14, 2024
Nanalysis Announces New Director and Results of AGM
June 28, 2024
Nanalysis Announces Grant of Stock Options
June 7, 2024
Nanalysis Announces First Quarter 2024 Results
May 29, 2024
Nanalysis Announces First Quarter 2024 Conference Call
May 21, 2024
Nanalysis Announces Fourth Quarter and Full Year 2023 Results
April 29, 2024
/C O R R E C T I O N -- Nanalysis Scientific Corp./
April 24, 2024
Nanalysis Announces Full Year 2023 Conference Call
April 11, 2024
Nanalysis Scientific Corp. Announces Director Resignation
April 10, 2024
Nanalysis Corp. Receives Funding Supporting AI Software Development for Detection of Illicit Substances
April 4, 2024
NANALYSIS ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND C...
March 20, 2024
Canadian Investment Regulatory Organization Trade Resumption - NSCI
March 6, 2024
Canadian Investment Regulatory Organization Trading Halt - NSCI
March 6, 2024
NANALYSIS ANNOUNCES UP TO $5.0 MILLION BEST EFFORTS PROSPECTUS EXEMPT OFFERING PURSUANT TO THE LISTED ISSUER EXEMPTION AND UP TO $1.0 MIL...
March 6, 2024